Summary
40-60% of addiction risk is genetic, but recovery approaches work regardless of predisposition. 12-step programs remain highly effective as free, accessible community support with strong long-term outcomes. Emerging treatments like TMS, SAINT protocol, and ibogaine show promise when integrated into clinical care.
Key Points
- Approximately 40-60% of addiction risk is heritable, making some individuals more vulnerable to developing dependencies than others
- Alcohol carries substantial health risks beyond addiction, including increased cancer risk, with social pressure often driving problematic use
- Modern cannabis products pose greater risks due to dramatically increased THC concentrations and potential links to psychosis in developing brains
- 12-step programs like AA remain highly effective, offering accessible, low-cost community support with strong evidence for long-term recovery
- Emerging neuromodulation therapies show promise, including transcranial magnetic stimulation (TMS) and Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT)
- Gambling machines and social media employ sophisticated behavioral techniques specifically engineered to maximize engagement and dependence
- Psychedelics and ibogaine show potential for addiction treatment when integrated into clinical protocols
Key Moments
TMS can treat addiction by targeting brain areas
Transcranial magnetic stimulation non-invasively modulates brain activity in addiction, with strong double-blind evidence.
"You can put these coils on the head. It feels like something's happening, and it's just a sham. People can't guess which condition they're in."
